1. Home
  2. CTGO vs ARMP Comparison

CTGO vs ARMP Comparison

Compare CTGO & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Contango ORE Inc.

CTGO

Contango ORE Inc.

HOLD

Current Price

$22.53

Market Cap

382.6M

ML Signal

HOLD

ARMP

Armata Pharmaceuticals Inc.

HOLD

Current Price

$11.03

Market Cap

383.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTGO
ARMP
Founded
2009
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
382.6M
383.7M
IPO Year
2010
1996

Fundamental Metrics

Financial Performance
Metric
CTGO
ARMP
Price
$22.53
$11.03
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$41.00
$15.00
AVG Volume (30 Days)
550.9K
55.6K
Earning Date
05-13-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
19.77
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.17
$1.17
52 Week High
$34.38
$14.98

Technical Indicators

Market Signals
Indicator
CTGO
ARMP
Relative Strength Index (RSI) 49.80 49.00
Support Level $22.10 $5.14
Resistance Level $26.42 $12.11
Average True Range (ATR) 1.36 1.40
MACD 0.14 0.00
Stochastic Oscillator 36.19 31.95

Price Performance

Historical Comparison
CTGO
ARMP

About CTGO Contango ORE Inc.

Contango Ore Inc operates in the United States. The company is engaged in the exploration of gold, silver, and copper ores in the State of Alaska. The company's focus is the exploration of a mineral lease with the Native Village of Tetlin whose governmental entity is the Tetlin Tribal Council for the exploration of minerals near Tok, Alaska. It has formed a joint venture to advance exploration of the Tetlin Property, which is prospective for gold and associated minerals. The Peak Gold JV Property is located in the Tetlin Hills and Mentasta Mountains of eastern interior Alaska. Its exploration projects are Lucky Shot, Johnson Tract, Eagle, Hona, Shamrock, and Triple Z.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

Share on Social Networks: